Citation only
via OpenAlex
Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19
Saad Bin Zafar Mahmood, Hafsa Majid, Ainan Arshad, Zaibunnisa Zaibunnisa, Noureen Niazali, Kulsum Kazi, Aashir Aslam, Sibtain Ahmed, Bushra Jamil, Lena Jafri
Clinical Laboratory · 2023 · ▲ 6 citations
Abstract
BACKGROUND: Interleukin-6 (IL-6) has been known to be involved in immune regulation, inflammatory response, and metabolism. It is also recognized as the major cause to underscore the pathology of severe COVID-19 patients. However, it remains to be seen if IL-6 is superior to other inflammatory biomarkers in ascertaining clinical severity and mortality rate for COVID-19. This study aimed to determine the value of IL-6 as a predictor of severity and mortality in COVID-19 patients and compare it with other pro-inflammatory biomarkers in the South Asian region. METHODS: An observational study was conducted, including all adult SARS-CoV-2 patients who had undergone IL-6 testing from December 2020 to June 2021. The patients' medical records were reviewed to collect demographic, clinical, and biochemical data. Other pro-inflammatory biomarkers apart from IL-6 included Neutrophils to Lymphocyte Ratio (NLR), D-dimer, C-reactive protein (CRP), ferritin, lactate dehydrogenase (LDH), and procal-citonin for analysis. SPSS version 22.0 was utilized. RESULTS: Out of the 393 patients who underwent IL-6 testing, 203 were included in the final analysis with a mean (SD) age of 61.9 years (12.9) and 70.9% (n = 144) were male. Fifty-six percent (n = 115) subjects had critical disease. IL-6 levels were elevated (> 7 pg/mL) in 160 (78.8%) patients. Levels of IL-6 significantly correlated with age, NLR, D-dimer, CRP, ferritin, LDH, length of stay, clinical severity, and mortality. All the inflammatory markers were significantly increased in critically ill and expired patients (p < 0.05). The receiver operator curve showed that IL-6 had the best area under the curve (0.898) compared to other pro-inflammatory biomarkers for mortality with comparable results for clinical severity. CONCLUSIONS: Study findings show that though IL-6 is an effective marker of inflammation and can be helpful for clinicians in recognizing patients with severe COVID-19. However, we still need further studies with larger sample size.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.7754/clin.lab.2022.220741
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Mahmood, S.B.Z., Majid, H., Arshad, A., Zaibunnisa, Z., Niazali, N., Kazi, K., Aslam, A., Ahmed, S., Jamil, B., & Jafri, L. (2023). Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19. <em>Clinical Laboratory</em>. https://doi.org/10.7754/clin.lab.2022.220741
Vancouver
Mahmood SBZ, Majid H, Arshad A, Zaibunnisa Z, Niazali N, Kazi K, et al. Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2022.220741.
BibTeX
@article{saad2023Interl,
title = {Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19},
author = {Saad Bin Zafar Mahmood and Hafsa Majid and Ainan Arshad and Zaibunnisa Zaibunnisa and Noureen Niazali and Kulsum Kazi and Aashir Aslam and Sibtain Ahmed and Bushra Jamil and Lena Jafri},
journal = {Clinical Laboratory},
year = {2023},
doi = {10.7754/clin.lab.2022.220741},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2022
Citation only
S45 Inflammatory biomarkers as predictors of mortality and persistent symptoms at follow-up in patients with severe COVID-19
Medica Hospitalia Journal of Clinical Medicine 2023
Open access · CC-BY
Influence of inflammatory factors (IL-6, CRP, NLPR, D-Dimer, LDH) on the PaO2/FiO2 ratio, in patients with severe and critical degrees of COVID-19
2022
Preprint · OA
Inflammatory Biomarkers as Predictors of Mortality and Persistent Symptoms at Follow-up in Patients with Severe COVID-19
Journal of Fatima Jinnah Medical University 2022
Open access · CC-BY
Correlation of inflammatory biomarkers with disease severity in hospitalised patients of COVID-19 at presentation
Austin Journal of Infectious Diseases 2023
Open access · OA
Hypoalbuminemia, Hyper-a-1/–a-2-Globulinemia Associated with High CRP and IL-6 in COVID-19 Patients in Togo
Immunity Inflammation and Disease 2023
Open access · CC-BY